Key result
Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder was successful in 98% of patients, with no cases of erosion, late embolization, or death during mid-term follow-up.
Why the study?
Is transcatheter closure of secundum ASDs using the Amplatzer septal occluder safe and effective in pediatric and young adult patients?
Population
208 consecutive patients with a significant secundum atrial septal defect, median age 7.3 years, 65% female…
Design
Cohort
Follow-up
mean 2.5 years (2.4±1.3 years)
Authors
Loading...
Supports mid-term safety of Amplatzer ASD closure in young patients; leaves open need for randomized trials versus surgery.
Cohort (n=208)
No
Is transcatheter closure of secundum ASDs using the Amplatzer septal occluder safe and effective in pediatric and young adult patients?
Transcatheter closure of secundum ASDs using the Amplatzer septal occluder is safe and effective in children and young adults, with excellent mid-term outcomes and no major late complications when appropriate sizing is used.
Ueda et al. (2012) conducted a cohort in Secundum atrial septal defect (n=208). Amplatzer septal occluder (ASO) was evaluated on Successful device closure. Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder was successful in 98% of patients, with no cases of erosion, late embolization, or death during mid-term follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: